An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results